Remove Insulin Remove Marketing Remove Packaging
article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Understanding the role of recombinant insulin in cell culture systems: What the studies say 

Pharmaceutical Technology

Among several growth-promoting supplements added to the cell culture media formulations, insulin is one of the most common. Recombinant insulin is used as a supplement in the upstream manufacturing of a range of biologic drugs, including recombinant proteins, such as monoclonal antibodies, viral vectors, and viruses.

Insulin 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Roche debuts smart glucose monitor for hospital use

pharmaphorum

” The Android-powered device can run certified third-party software, initially shipping with a handful of apps including Glytec’s Glucommander insulin-dosing software under the terms of a deal announced today. The unit is rechargeable, wipe clean so it can be easily disinfected, and can be used hands free, according to Roche.

Insulin 128
article thumbnail

GLP1 Receptor Agonist Market: Current Landscape, Growth Opportunities and Future Market Outlook

Roots Analysis

GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. GLP-1 Receptor Agonist Market – Current Landscape Presently, more than 150 GLP-1 drug candidates have been commercialized / being developed by more 55 developers to treat various metabolic disorders.

article thumbnail

Provention Bio Launches Campaigns for Familial Type 1 Diabetes Screening

XTalks

Autoantibody screening involves measuring levels of islet autoantibodies (iAb) that recognize antigens found in insulin-producing pancreatic beta cells. She said that’s why it’s “so important that we educate the market with campaigns like the ones we’ve launched.”

Insulin 98
article thumbnail

This is the Newest Functional Beverage from the Co-Founders of Oatly and Fiji Water

XTalks

Following a soft launch in select markets, the beverage buffs behind Oatly and Fiji Water have teamed up to develop Good Idea , a functional beverage that will soon debut in the US. Good Idea is tapping into the massive market of consumers concerned about their blood sugar.

article thumbnail

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

pharmaphorum

Though Novo Nordisk is perhaps not as much of a household name as other pharma companies in the UK, it has a huge presence in diabetes, with a bigger market cap than the likes of GSK and AstraZeneca – and UK GM Pinder Sahota is keen to shout about the organisation that he describes as a “sleeping giant”. Collaborating to prevent diabetes.